All Exams Test series for 1 year @ ₹349 only
Question

Consider the following statements about Centralized Laboratory Net- work (CLN):

1. CLN works to test vaccines can be used during which pandemic

2. India is a member of CLN

3. CLN is a part of the Coalition for Epidemic Preparedness Innovations (CEPI)

Which of the statements given above is/are correct?

This question was previously asked in
NDA I 2023 GAT Previous Year Paper (16-Apr-2023)
The correct answer is

1, 2 and 3

Analyzing Statements about the Centralized Laboratory Network (CLN)

The question asks us to evaluate three statements regarding the Centralized Laboratory Network (CLN). Let's examine each statement carefully to determine its correctness.

Statement 1: CLN works to test vaccines can be used during which pandemic

This statement implies that the CLN's function includes testing vaccines for use during pandemics. The Centralized Laboratory Network (CLN), often associated with the Coalition for Epidemic Preparedness Innovations (CEPI), plays a crucial role in preparing for future epidemics and pandemics. One of the key aspects of pandemic preparedness is the rapid development and testing of vaccines and other countermeasures. Laboratory networks like CLN are essential for standardizing testing methodologies, evaluating candidate vaccines, and ensuring data comparability across different locations during a health crisis like a pandemic. Therefore, testing vaccines for pandemic use aligns with the core purpose of such a network.

Statement 2: India is a member of CLN

Global health initiatives often involve participation from various countries to enhance preparedness and response capabilities worldwide. India has been actively involved in global health collaborations and initiatives related to vaccine development and pandemic preparedness. Reports and information from organizations like CEPI confirm India's participation in the Centralized Laboratory Network (CLN). India's membership is significant for strengthening the network's capacity and geographical reach.

Statement 3: CLN is a part of the Coalition for Epidemic Preparedness Innovations (CEPI)

The Coalition for Epidemic Preparedness Innovations (CEPI) is a partnership that funds and catalyzes the development of vaccines against emerging infectious diseases. To effectively support vaccine development and evaluation, CEPI established the Centralized Laboratory Network (CLN). The CLN works with laboratories around the world to provide standardized assessment of vaccine candidates developed against CEPI's priority pathogens. This makes the CLN an integral part of CEPI's strategy for pandemic preparedness.

Conclusion based on the analysis:

  • Statement 1 is correct as the CLN's work supports vaccine testing relevant to pandemics.
  • Statement 2 is correct as India is a member of the CLN.
  • Statement 3 is correct as the CLN is established and operated as part of CEPI's initiative.

Since all three statements are found to be correct, the option that includes statements 1, 2, and 3 is the correct choice.

Revision Table: Centralized Laboratory Network (CLN)

Feature Description / Relation
Purpose Standardized testing and evaluation of vaccine candidates, especially for emerging infectious diseases and pandemics.
Affiliation Part of the Coalition for Epidemic Preparedness Innovations (CEPI).
Membership Includes laboratories from various countries, including India.
Role in Pandemics Facilitates rapid and comparable testing of vaccines developed during outbreaks.

Additional Information on CLN and CEPI

The Centralized Laboratory Network (CLN) is a critical component in the global health architecture aimed at preventing and containing future epidemics. By standardizing laboratory procedures and assays, the CLN ensures that results from different labs evaluating the same vaccine candidate are comparable and reliable. This is particularly important during the rapid pace of a pandemic response.

CEPI, the parent initiative, was launched in 2017 with the goal of accelerating the development of vaccines against known and unknown infectious diseases that could cause future epidemics or pandemics. CEPI funds projects globally and works closely with partners across governments, industry, philanthropy, and civil society. The CLN is one of the practical mechanisms CEPI employs to achieve its mission of developing safe and effective vaccines against epidemic threats quickly.

India's role in the CLN is significant, highlighting its growing capacity in vaccine research and development and its commitment to global health security. Participation in such networks allows countries to contribute their expertise and resources while also benefiting from shared knowledge and standardized protocols, enhancing their national preparedness.

Was this answer helpful?
The correct answer is

1, 2 and 3

Statement 1: CLN works to test vaccines that can be used during a pandemic

✔️ Correct

CLN is a global initiative to support standardized testing and evaluation of vaccines, especially during pandemics and epidemics.

It ensures that vaccines are tested rapidly, reliably, and uniformly.

Statement 2: India is a member of CLN

✔️ Correct

India is a part of the CLN, and laboratories from India are included in this global network.

Statement 3: CLN is a part of the Coalition for Epidemic Preparedness Innovations (CEPI)

✔️ Correct

CLN operates under the framework of CEPI, which is a global partnership working to accelerate vaccine development against emerging infectious diseases.

✅ Therefore, All three statements are correct.

Was this answer helpful?
The correct answer is

1, 2 and 3

The first statement is indeed valid. CLN is designed to test vaccines that can be used during pandemics or epidemic outbreaks.

The second statement is correct, as India is a member of the CLN, represented by the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV).

The third statement is also accurate. CLN is a part of the Coalition for Epidemic Preparedness Innovations (CEPI), which focuses on accelerating vaccine development for emerging infectious diseases.

Thus, the correct answer should be: 1, 2, and 3.

Was this answer helpful?

Similar Questions

  1. Which of the following is India's first privately developed rocket launched by ISRO recently?


Important Questions from Science and Technology

  1. As per an announcement made by the Chairman of ISRO on 6 September 2021, Chandrayaan-2 had completed ______ revolutions of the Moon.

  2. On 7 September 2021, NASA announced that the Perseverance rover has completed the collection of the first sample of _______ Mars.

  3. What is the range of a BrahMos to Les Sukhoi-30 in one go without mid-air refueling?

  4. Which of the following countries performed its first robotic docking in lunar orbit?

  5. Which satellite-based system that was launched by the Indian National Centre for Ocean Information Services (INCOIS) and Airport Authority of India (AAI) in October 2019 will alert deep-sea fishermen of upcoming disasters?

Need Expert Advice?
Upcoming Exams
NDA
September 13, 2026
CDS
September 13, 2026
Test Series
NDA img
Defence
NDA 2026 Mock Test Series (Latest Pattern)
501 Tests 1 Tests Free
677 Attempts
4.6(121)
English, Hindi

Start Your Preparation with Prepp Mobile App

Download the app from Google Play & App Store
Download the app from Google Play & App Store
Prepp Mobile App